Miranda Davies

7PUBLICATIONS
21CO-AUTHORS
PharmacogenomicsCheminformatics and quantitative structure-activity relationshipsAdolescent healthMedical devicesRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 05, 2026
Current Challenges in Monitoring the Safety and Utilisation of the Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs): A UK Perspective.

|Mar 30, 2026
A Scoping Review of Case-Level Causality Assessment Tools Developed Between 2008 and 2023; Strengths, Weaknesses and Potential Future Improvements.

Dawn Cooper, Mohammed Toseef Ansari, Taylor Aurelius

|May 02, 2025
Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study.

Alison Evans, Debabrata Roy, Miranda Davies

|Mar 07, 2025
Safety and effectiveness of the anti-amyloid monoclonal antibody (mAb) drug lecanemab for early Alzheimer's disease: The pharmacovigilance perspective.

Amy Bobbins, Miranda Davies, Elizabeth Lynn

|Nov 05, 2020
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study.

Alison Evans, Miranda Davies, Vicki Osborne

|Jul 24, 2020
Rationale and design of a European epidemiological post-authorization safety study (PASS) program: rivaroxaban use in routine clinical practice.

Luis Alberto García-Rodríguez, Mari-Ann Wallander, Leif Friberg

Pageof 2

Frequent Collaborators

3 joint publications

Alison Evans

2 joint publications

Saad Shakir

2 joint publications

Debabrata Roy

1 joint publications

Luis Alberto García-Rodríguez